liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Gene-specific ACMG/AMP classification criteria for germline APC variants: Recommendations from the ClinGen InSiGHT Hereditary Colorectal Cancer/Polyposis Variant Curation Expert Panel
Institute of Human Genetics, Medical Faculty, University of Bonn, Bonn, Germany; National Center for Hereditary Tumor Syndromes, University Hospital Bonn, Bonn, Germany.
Institute of Human Genetics, Medical Faculty, University of Bonn, Bonn, Germany; Department of Colorectal Medicine and Genetics, Royal Melbourne Hospital, Parkville, Australia; Department of Medicine, University of Melbourne, Parkville, Australia.
Ambry Genetics, Aliso Viejo, CA, USA.
European Reference Network on Genetic Tumour Risk Syndromes (ERN GENTURIS) - Project ID No 739547; Hereditary Cancer Program, Catalan Institute of Oncology - ONCOBELL, IDIBELL, Barcelona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto Salud Carlos III, Madrid, Spain.
Show others and affiliations
2024 (English)In: Genetics in Medicine, ISSN 1098-3600, E-ISSN 1530-0366, Vol. 26, no 2, article id 100992Article in journal (Refereed) Published
Abstract [en]

Purpose: The Hereditary Colorectal Cancer/Polyposis Variant Curation Expert Panel (VCEP) was established by the International Society for Gastrointestinal Hereditary Tumours and the Clinical Genome Resource, who set out to develop recommendations for the interpretation of germline APC variants underlying Familial Adenomatous Polyposis, the most frequent hereditary polyposis syndrome. Methods: Through a rigorous process of database analysis, literature review, and expert elicitation, the APC VCEP derived gene-specific modifications to the ACMG/AMP (American College of Medical Genetics and Genomics and Association for Molecular Pathology) variant classification guidelines and validated such criteria through the pilot classification of 58 variants. Results: The APC-specific criteria represented gene- and disease-informed specifications, including a quantitative approach to allele frequency thresholds, a stepwise decision tool for truncating variants, and semiquantitative evaluations of experimental and clinical data. Using the APC-specific criteria, 47% (27/58) of pilot variants were reclassified including 14 previous variants of uncertain significance (VUS). Conclusion: The APC-specific ACMG/AMP criteria preserved the classification of well-characterized variants on ClinVar while substantially reducing the number of VUS by 56% (14/25). Moving forward, the APC VCEP will continue to interpret prioritized lists of VUS, the results of which will represent the most authoritative variant classification for widespread clinical use.

Place, publisher, year, edition, pages
Elsevier, 2024. Vol. 26, no 2, article id 100992
Keywords [en]
ACMG/AMP variant classification guidelines, Adenomatous polyposis coli (APC), ClinGen, Familial adenomatous polyposis (FAP), InSiGHT, Adenomatous Polyposis Coli, Genetic Testing, Genetic Variation, Germ Cells, Germ-Line Mutation, Humans, APC protein, bone morphogenetic protein receptor 1A, DNA glycosylase MutY, protein kinase LKB1, Smad4 protein, APC gene, Article, BMPR1A gene, cancer classification, computer model, controlled study, familial adenomatous polyposis, gene, gene frequency, gene function, gene identification, genetic association, genetic variability, germline mutation, hereditary colorectal cancer, human, human tissue, loss of function mutation, missense mutation, mutational analysis, MUTYH gene, POLD1 gene, POLE gene, predictive value, SMAD4 gene, STK11 gene, colon polyposis, genetic screening, genetics, germ cell, procedures
National Category
Medical Genetics and Genomics
Identifiers
URN: urn:nbn:se:liu:diva-211878DOI: 10.1016/j.gim.2023.100992ISI: 001178153300001PubMedID: 37800450Scopus ID: 2-s2.0-85179054274OAI: oai:DiVA.org:liu-211878DiVA, id: diva2:1941595
Note

Funding agencies: the Dutch Digestive Foundation (grant FP 16-01) and the Dutch Cancer Society (grant UL 20135939)

Available from: 2025-03-01 Created: 2025-03-01 Last updated: 2026-03-13

Open Access in DiVA

fulltext(1741 kB)71 downloads
File information
File name FULLTEXT01.pdfFile size 1741 kBChecksum SHA-512
dbc1d9b0835b8ab75ddd31524b80b05010c6a2891e4dd79f6a7ed9b956251baee27f056b7a8dc8a1299bd4a1fb176d45a4783fe5716d88341a75161ccb318627
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMedScopus

Authority records

Nordling, Margareta

Search in DiVA

By author/editor
Nordling, Margareta
By organisation
The Division of Cell and NeurobiologyFaculty of Medicine and Health SciencesClinical genetics
In the same journal
Genetics in Medicine
Medical Genetics and Genomics

Search outside of DiVA

GoogleGoogle Scholar
Total: 74 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 1093 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf